Aims-To develop a non-radioactive method to screen routinely fixed, paraffin wax embedded specimens for the occurrence of point mutations; to evaluate the single strand conformational polymorphism (SSCP) analysis technique for the detection of K-ras point mutations as a result of electrophoretic mobility shifts. Methods-DNA was extracted from archival specimens of colon cancer and from established colon cancer cell lines with known point mutations. A K-ras gene fragment containing codons 12 and 13 of exon 1 was amplified with the polymerase chain reaction (PCR). Denatured DNA fragments were run on 10% polyacrylamide gels under non-denaturing conditions. After electrophoresis DNA was blotted and the single stranded DNA was detected using a digoxigenin labelled ras probe. The nature of the detected point mutations was identified and confirmed by sequencing and hybridisation with oligonucleotides using 32P labelling.
gene fragment containing codons 12 and 13 of exon 1 was amplified with the polymerase chain reaction (PCR). Denatured DNA fragments were run on 10% polyacrylamide gels under non-denaturing conditions. After electrophoresis DNA was blotted and the single stranded DNA was detected using a digoxigenin labelled ras probe. The nature of the detected point mutations was identified and confirmed by sequencing and hybridisation with oligonucleotides using 32P labelling.
Results-Wild type and aberrant alleles were detected caused by mobility shifts after electrophoresis of the PCR products. Commonly occurring mutations in the K-ras gene-in the first two positions of codon 12-could easily be detected in DNA from archival paraffin wax embedded colon cancer tissue. In all the colon tumour samples studied wild type gene alleles were also found, presumably derived from normal cells in the specimen.
Conclusions-The SSCP method permits rapid non-radioactive screening of adenomas or carcinomas for the occurrence of point mutations in the K-ras gene. But if a mutation is detected by an electrophoretic mobility shift, its identification requires confirmation by sequencing or oligonucleotide hybridisation. The first exon of the K-ras gene, which includes codons 12 and 13, was amplified with the PCR in 15 cycles with a primer set to obtain a 280 base pair fragment, followed by 25 cycles with a set of inserted primers. This latter set of primers [sense sequence 5' AAA ATG ACT GAA TAT AAA CTT GTG G 3', antisense sequence 5' CTC TAT TGT TGG ATC ATA TTC GTC 3'] resulted in PCR products with a length of 1 4 base pairs.4 The conditions of PCR were: denaturation for 3 minutes at 95°C; 25 cycles of 1 minute at 92°C, 2 minutes at 62°C, 3 minutes at 72°C; followed by 10 minutes at 720C.
These PCR products were loaded on a non-denaturating 10% polyacrylamide gel containing 10% glycerol.' DNA (05 ng) dissolved in a solution containing 95% formamide, 20 mM EDTA, 0-05% bromophenol blue and 0-05% xylene cyanol was heated at 1 000C for 10 minutes, then figure. The nature of the detected mutations was revealed with radioactive sequencing and with allele specific oligohybridisation (data not shown) (figure). The alleles with codon 12 wild type GGT could be observed as two bands on the gel in lane 1 and in all tumour samples in lanes 5-9. Substitutions in the first position of codon 12 were identified as TGT represented by two extra bands in lanes 2, 6, and 7, and the AGT mutation was seen in lane 9. Substitutions in the second base of the codon were detected as GCT, which was visualised in lane 3, and as GTT in lanes 4 and 5. The results show that the most frequently occurring point mutations in the K-ras gene-in the first two positions of codon 12-can be detected with this technique. In all colon tumour samples studied wild type gene alleles occurred in addition to mutated alleles. These are presumably derived from normal cells in the specimen. Discussion SSCP analysis alone is not sufficient to establish the nature of the (point) mutation, not even when samples with known point mutations are run in parallel lanes on the gel. Therefore, radioactive sequencing and hybridisation with oligonucleotides were used to identify the mutations and seemed to confirm the SSCP results. It cannot be concluded from this study, however, that all point mutations occurring in the K-ras gene fragment can be detected using SSCP analysis, because it is not known whether each mutation results in an electrophoretic mobility shift.
The question arises as to whether this SSCP technique has advantages over other non-radioactive methods for screening paraffin wax embedded tissue samples for point mutations. The SSCP technique was not compared experimentally with non-radioactive methods, but it can be argued that its sensitivity and probably its specificity are significantly greater. A modification of the SSCP method described would be to omit the hybridisation step. This means using PCR with biotinylated or digoxigenin labelled primers, followed by electrophoresis, blotting, and visualisation with avidin or anti-digoxigenin respectively. We assume, however, a lower sensitivity due to less efficient amplification in the PCR step, caused by the modified primers, and in the detection step on the blot.
Non-radioactive sequencing could be a good alternative. It is not clear, however, whether its sensitivity is sufficient to detect minor proportions of aberrant sequences. We also do not expect significant gains in terms of speed and effort for this technique.
Another method would be allele specific oligonucleotide hybridisation but this approach has two main disadavantages. Firstly, because of the small size of the oligonucleotides, the introduction of only a few nucleotides per probe tagged with biotin or digoxigenin will decrease effective hybridisation and consequently the specificity of the method. Secondly, for every point mutation to be studied a specifically labelled probe has to be applied and optimal hybridisation conditions have to be established.
Another approach could be the performance of PCR with primers with mismatched 3' residues (ARMS), which results in amplification of only the mutated DNA fragments.7 This technique might be very useful for the detection of very small numbers of genes with known point mutations in the presence of large amounts of wild type alleles. We have no experience of the latter method, but we feel that adequate results critically depend on the experimental conditions of the PCR and the quality of the DNA, which is certainly not optimal for archival, paraffin wax embedded material.
The use and detection of the 114 base pair probe, labelled with digoxigenin-dUTP used in this study, is apparently sensitive enough to detect the common mutations in K-ras genes from cell lines and paraffin wax embedded tumour specimens. In contrast to oligonucleotide hybridisation and the PCR with mismatch 3' nucleotide primers, the SSCP method has the potential to reveal other (point) mutations than would be expected in the amplified gene fragment. On the other hand, a low proportion of point mutations in a sample or mutations that do not result in a mobility shift will not be detected using this technique.
We conclude that this non-radioactive method may be valuable for the screening of premalignant and malignant tissues or cells for the occurrence of K-ras point mutations. It has the advantages of sensitivity, speed, and applicability in the routine diagnostic pathology laboratory. DNA extracted from routinely fixed tissue can also be used for electrophoretic analysis. Application of adequate control samples with known mutations can give an initial indication of the genetic aberration. When a mobility shift is detected on the blot, however, confirmation and identification of the mutation with established methods such as sequencing or eventually hybridisation with oligonucleotides specific for the point mutation is required. 
